These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15573308)

  • 21. [Sexual intercourse as a trigger of transient global amnesia].
    Velasco R; Al-Hussayni S; Bermejo PE
    Rev Neurol; 2008 Sep 16-30; 47(6):301-3. PubMed ID: 18803157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New aspects of headache treatment].
    Pichler E
    Monatsschr Ohrenheilkd Laryngorhinol; 1966 Dec; 100(12):544-50. PubMed ID: 16114452
    [No Abstract]   [Full Text] [Related]  

  • 23. The transient global amnesia-migraine connection. Case report.
    Santoro G; Casadei B; Venco A
    Funct Neurol; 1988; 3(3):353-60. PubMed ID: 3192108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Variant angina pectoris related to the treatment of migraine].
    Gómez Barrado JJ; Turégano Albarrán S; García Rubira JC; Hidalgo Urbano R; Rodríguez Revuelta M; Pérez Leal I; García Martínez JT; González López M; Cruz Fernández JM
    Rev Esp Cardiol; 1995 Sep; 48(9):628-30. PubMed ID: 7569265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Migraine treatment].
    Noth J
    Dtsch Med Wochenschr; 2000 Mar; 125(13):408. PubMed ID: 10778403
    [No Abstract]   [Full Text] [Related]  

  • 26. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of transformed refractory migraine with intravenous dihydroergotamine].
    Cid C; Ortega-Valín F; Valero M; Muñoz R; Pascual J
    Neurologia; 1999; 14(6):315-8. PubMed ID: 10439626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transient global amnesia: a review. I. Clinical aspects].
    Marín-Garcia E; Ruiz-Vargas JM
    Rev Neurol; 2008 Jan 1-15; 46(1):53-60. PubMed ID: 18214828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ergotamine-induced disorders of the peripheral blood circulation--a case report].
    Creutzig A; Kamin K; Flöge J; Wannske M; Alexander K; Wagner HH
    Rontgenblatter; 1985 Jun; 38(6):193-5. PubMed ID: 4023577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Migraine and stroke].
    Hauge A
    Tidsskr Nor Laegeforen; 1998 May; 118(12):1910. PubMed ID: 9638061
    [No Abstract]   [Full Text] [Related]  

  • 31. Coronary side-effect potential of current and prospective antimigraine drugs.
    MaassenVanDenBrink A; Reekers M; Bax WA; Ferrari MD; Saxena PR
    Circulation; 1998 Jul; 98(1):25-30. PubMed ID: 9665056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of drugs in migraine].
    Wilkinson M
    Minerva Med; 1976 Jun; 67(28):1867-70. PubMed ID: 934533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long lasting recurrent familiar transient global amnesia after betablocker treatment withdrawal: case report.
    Vyhnálek M; Bojar M; Jerabek J; Hort J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):44-6. PubMed ID: 18283253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of right-left shunt in transient global amnesia].
    de Francisco J; Pujadas F; Toledo M; Santamarina E; Quintana M; Edo MC; Centeno M; Alvarez Sabín J
    Neurologia; 2010 Mar; 25(2):83-9. PubMed ID: 20487707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient Global Amnesia Triggered by Migraine in a French Tertiary-Care Center: An 11-Year Retrospective Analysis.
    Donnet A
    Headache; 2015 Jun; 55(6):853-9. PubMed ID: 25877480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal infarction due to ergotamine.
    Sran HK; Vathsala A
    QJM; 2016 Nov; 109(11):749-750. PubMed ID: 27654501
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letter: Coronary spasm following ergotamine medication].
    Schwalb H
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1437. PubMed ID: 809691
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine.
    Stead M; Josephs KA
    Headache; 2005 Apr; 45(4):378-80. PubMed ID: 15836577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of ischemic complications related to the intensity of triptan and ergotamine use.
    Wammes-van der Heijden EA; Rahimtoola H; Leufkens HG; Tijssen CC; Egberts AC
    Neurology; 2006 Oct; 67(7):1128-34. PubMed ID: 17030745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Migraine: dihydroergotamine nasal spray--an alternative].
    Beubler E
    Wien Med Wochenschr; 1995; 145(14):326-31. PubMed ID: 7483646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.